Natera

$102.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$6.55 (-6.03%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Natera and other stocks, options, and ETFs commission-free!

About NTRA

Natera, Inc. Common Stock, also called Natera, is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA. The listed name for NTRA is Natera, Inc. Common Stock.

CEO
Stephen Chapman
Employees
1,039
Headquarters
San Carlos, California
Founded
2003
Market Cap
8.66B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
944.97K
High Today
$109.60
Low Today
$101.15
Open Price
$106.87
Volume
1.73M
52 Week High
$127.19
52 Week Low
$16.87

NTRA Earnings

-$0.89
-$0.70
-$0.52
-$0.33
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.62 per share
Actual
-$0.89 per share
Replay Earnings Call

You May Also Like

EWH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure